EKSO - Ekso Bionics Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EKSO is currently covered by 1 analysts

Ekso Bionics Holdings's activity chart (see below) currently has 10 price targets and 16 ratings on display. The stock rating distribution of EKSO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 351 days.

Highest price target for EKSO is $9, Lowest price target is $4.

Most recent stock forecast was given by from HC WAINWRIGHT on 31-Dec-2025. First documented stock forecast 15-Jun-2020.

Best performing analysts who are covering EKSO - Ekso Bionics Holdings:

Swayampakula Ramakanth Ben Haynor

Currently out of the existing stock ratings of EKSO, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Jul-2025

$9.5

$-2.3 (-19.49%)

Show more analysts

Please expand the browser size to see the chart

What is EKSO (Ekso Bionics Holdings) average time for price targets to be met?

On average it took 351 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on EKSO (Ekso Bionics Holdings) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on EKSO (Ekso Bionics Holdings)?

Swayampakula Ramakanth has 51 price targets and 35 ratings on EKSO

Which analyst is the currently most bullish on EKSO (Ekso Bionics Holdings)?

Swayampakula Ramakanth with highest potential upside - $0

Which analyst is the currently most reserved on EKSO (Ekso Bionics Holdings)?

Ben Haynor with lowest potential downside - -$2.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?